Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S A Halperin

Showing results (51-60 of 93) with videos related to

Pageof 10
Sort By:
Archives of Pediatrics & Adolescent Medicine|November 1, 1994
Safety and immunogenicity of a five-component acellular pertussis vaccine with varying antigen quantitiesS A Halperin, L Barreto, B J Eastwood, et al.
Infection and Immunity|February 20, 1999
Surface expression of a protective recombinant pertussis toxin S1 subunit fragment in Streptococcus gordoniiS F Lee, R J March, S A Halperin, et al.
Vaccine|February 1, 1997
Estimates of the effectiveness of a whole-cell pertussis vaccine from an outbreak in an immunized populationA D Bentsi-Enchill, S A Halperin, J Scott, et al.
The Journal of Infectious Diseases|February 1, 1987
Antibody response to bacteriophage hyaluronidase in acute glomerulonephritis after group A streptococcal infectionS A Halperin, P Ferrieri, E D Gray, et al.
The Journal of Pediatrics|August 4, 1999
Extended follow-up of antibody levels and antigen responsiveness after 2 Haemophilus influenzae type b conjugate vaccinesD W Scheifele, S A Halperin, R Guasparini, et al.
The Journal of Pediatrics|October 1, 1992
Antibody response to Bordetella pertussis antigens after immunization with American and Canadian whole-cell vaccinesJ D Baker, S A Halperin, K Edwards, et al.
Canada Communicable Disease Report = Releve Des Maladies Transmissibles Au Canada|May 18, 2018
The Canadian Immunization Monitoring Program, ACTive (IMPACT): Active surveillance for vaccine adverse events and vaccine-preventable diseasesJ A Bettinger, S A Halperin, W Vaudry, et al.
Vaccine|February 1, 1997
Safety and immunogenicity of an acellular pertussis diphtheria tetanus vaccine given as a single injection with Haemophilus influenzae b conjugate vaccineS A Halperin, L Barreto, B J Eastwood, et al.
Scandinavian Journal of Immunology|March 17, 2009
Differential activation of dendritic cells by Toll-like receptor agonists isolated from the Gram-positive vaccine vector Streptococcus gordoniiM L Mayer, C M Phillips, R A Townsend, et al.
JAMA|April 19, 2000
Can meningococcal C conjugate vaccine overcome immune hyporesponsiveness induced by previous administration of plain polysaccharide vaccine?N E MacDonald, S A Halperin, B J Law, et al.
Pageof 10

Showing results (51-60 of 93) with videos related to

Sort By:
Pageof 10
Archives of Pediatrics & Adolescent Medicine|November 1, 1994
Safety and immunogenicity of a five-component acellular pertussis vaccine with varying antigen quantitiesS A Halperin, L Barreto, B J Eastwood, et al.
Infection and Immunity|February 20, 1999
Surface expression of a protective recombinant pertussis toxin S1 subunit fragment in Streptococcus gordoniiS F Lee, R J March, S A Halperin, et al.
Vaccine|February 1, 1997
Estimates of the effectiveness of a whole-cell pertussis vaccine from an outbreak in an immunized populationA D Bentsi-Enchill, S A Halperin, J Scott, et al.
The Journal of Infectious Diseases|February 1, 1987
Antibody response to bacteriophage hyaluronidase in acute glomerulonephritis after group A streptococcal infectionS A Halperin, P Ferrieri, E D Gray, et al.
The Journal of Pediatrics|August 4, 1999
Extended follow-up of antibody levels and antigen responsiveness after 2 Haemophilus influenzae type b conjugate vaccinesD W Scheifele, S A Halperin, R Guasparini, et al.
The Journal of Pediatrics|October 1, 1992
Antibody response to Bordetella pertussis antigens after immunization with American and Canadian whole-cell vaccinesJ D Baker, S A Halperin, K Edwards, et al.
Canada Communicable Disease Report = Releve Des Maladies Transmissibles Au Canada|May 18, 2018
The Canadian Immunization Monitoring Program, ACTive (IMPACT): Active surveillance for vaccine adverse events and vaccine-preventable diseasesJ A Bettinger, S A Halperin, W Vaudry, et al.
Vaccine|February 1, 1997
Safety and immunogenicity of an acellular pertussis diphtheria tetanus vaccine given as a single injection with Haemophilus influenzae b conjugate vaccineS A Halperin, L Barreto, B J Eastwood, et al.
Scandinavian Journal of Immunology|March 17, 2009
Differential activation of dendritic cells by Toll-like receptor agonists isolated from the Gram-positive vaccine vector Streptococcus gordoniiM L Mayer, C M Phillips, R A Townsend, et al.
JAMA|April 19, 2000
Can meningococcal C conjugate vaccine overcome immune hyporesponsiveness induced by previous administration of plain polysaccharide vaccine?N E MacDonald, S A Halperin, B J Law, et al.
Pageof 10